Novo Nordisk raises 2026 outlook as Wegovy pill sales reach 5.4 billion kroner

Novo Nordisk raises 2026 outlook as Wegovy pill sales reach 5.4 billion kroner

Updated at: November 5, 2026 at 01:18 AM

Novo Nordisk raised its 2026 outlook on November 4 after stronger sales of its obesity treatments. The Danish drugmaker now expects adjusted sales and adjusted operating profit each to change by between minus 2 and plus 2 percent at constant exchange rates over the full year.

nounoutlook

Third-quarter sales reached 79.195 billion Danish kroner, up 4 percent at constant exchange rates. The company said demand for GLP-1 products increased across both its US and international businesses, particularly in obesity care.

adverbparticularly

The Wegovy pill generated 5.394 billion kroner during the quarter. By the end of September it had launched in the United States, United Arab Emirates, Britain and Germany. Four more launches subsequently brought the number of markets to eight.

adverbsubsequently

Adjusted operating profit rose 27 percent to 31.720 billion kroner at constant exchange rates. The comparison benefited from 9 billion kroner of transformation costs recorded a year earlier, which had lowered the previous year’s base.

verbbenefit

Reported operating profit moved in the opposite direction, falling 9 percent on the same exchange-rate basis. It included 8.7 billion kroner in non-cash impairment charges related to a drug project and changes to the manufacturing network.

nounimpairment

Chief executive Mike Doustdar said the company was preparing for a US launch of CagriSema in early 2027, subject to regulatory approval. Broader access to medicines and continued international launches remain part of its plans.

phrasesubject to
πŸŽ‰

End of article

You read 6 focus sentences.

Challenge Mode

Comprehension Questions

What is the new adjusted annual growth range?

βœ“

Correct Choice

Minus 2 to plus 2 percent

How much did quarterly sales grow at constant exchange rates?

βœ“

Correct Choice

4 percent

How many markets had the Wegovy pill reached after later launches?

βœ“

Correct Choice

Eight

Why was the adjusted profit comparison helped?

βœ“

Correct Choice

The prior year included large transformation costs

When is the US CagriSema launch planned, subject to approval?

βœ“

Correct Choice

Early 2027

Ringoo Icon

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.